Osteosarcoma cells in early and late stages as cancer in vitro progression model for assessing the responsiveness of cells to silver nanoparticles
- 25 December 2021
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 110 (6), 1319-1334
- https://doi.org/10.1002/jbm.b.35002
Abstract
Understanding of biology of osteosarcoma malignant progression is indispensable for enhancement of conventional chemotherapy by the use of silver nanoparticles (AgNPs). We presented an in vitro model of cancer progression closely resembling processes occurring in vivo in terms of protein profile. A comparison of cytotoxic and genotoxic potential of AgNPs in Saos-2 cells in early stages of cancerous progression (early passages) with the cells in advanced stages (late passages) demonstrated significantly reduced responsiveness of the late passage cells to nanoparticles toxicity. It was also confirmed by proteome analysis as we identified considerably higher number of differentially expressed proteins in Saos-2 cells in early passages compared to the late passage cells. Our studies showed that the ability of AgNPs as potential drug carriers to deliver a medication and/or to evoke toxic effects might be significantly diminished in advanced stages of cancer progression.Keywords
Funding Information
- Narodowe Centrum Nauki (2017/26/D/ST4/00918)
This publication has 37 references indexed in Scilit:
- Annexin A5 as a potential marker in tumorsClinica Chimica Acta; International Journal of Clinical Chemistry, 2014
- Cytotoxicity of Biologically Synthesized Silver Nanoparticles in MDA-MB-231 Human Breast Cancer CellsBioMed Research International, 2013
- Discovery of Biomarkers for Osteosarcoma by Proteomics ApproachesSarcoma, 2012
- Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line SystemsSarcoma, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Induction of Apoptosis in Cancer Cells at Low Silver Nanoparticle Concentrations using Chitosan NanocarrierACS Applied Materials & Interfaces, 2011
- OsteosarcomaAnnals of Oncology, 2010
- Annexin A6-regulator of the EGFR/Ras signalling pathway and cholesterol homeostasisThe International Journal of Biochemistry & Cell Biology, 2010
- Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human CellsACS Nano, 2008
- A proteomic study on human osteoblastic cells proliferation and differentiationProteomics, 2006